TY - JOUR
T1 - NGAL decreases E-cadherin-mediated cellcell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells
AU - Hu, Limei
AU - Hittelman, Walter
AU - Lu, Tao
AU - Ji, Ping
AU - Arlinghaus, Ralph
AU - Shmulevich, Ilya
AU - Hamilton, Stanley R.
AU - Zhang, W.
N1 - Funding Information:
We thank Hong Zheng for her technical assistance. This study was partially supported by a grant from the National Foundation for Cancer Research, the Favrot Fund, the Wilson Fund, the Kadoorie Charitable Foundation, Cancer Center Support Grant P30 CA016672 from the National Cancer Institute, National Institutes of Health, and the Tobacco Settlement Fund to the MD Anderson Cancer Center as appropriated by the Texas State Legislature. Dr Hamilton is a recipient of the Frederick F Becker Distinguished University Chair in Cancer Research from The University of Texas. We thank Dr Randall Evans in the Image Analysis Core of MD Anderson Cancer Center for his help with confocal images; Dr Gregory Fuller and Lynda Corley in the Tissue Microarray Core for assistance with tissue microarray construction; and Dr Lucian Chirieac, Ellen Taylor, and Renee Webb for their technical support for immunohistochemistry studies. We also thank Ms Beth Notzon for editorial assistance.
PY - 2009/5
Y1 - 2009/5
N2 - Expression of neutrophil gelatinase-associated lipocalin (NGAL)lipocalin2, a recently recognized iron regulatory protein that binds to matrix metalloproteinase-9 (MMP9), is increased in a spectrum of cancers, including those of the colorectum. Using colon carcinoma cell lines stably transfected with NGAL or antisense NGAL, we showed that NGAL overexpression altered subcellular localization of E-cadherin and catenins, decreased E-cadherin-mediated cellcell adhesion, enhanced cellmatrix attachment, and increased cell motility and in vitro invasion. Conversely, a decrease in NGAL enhanced more aggregated growth pattern and decreased in vitro invasion. We further showed that NGAL exerted these effects through the alteration of the subcellular localization of Rac1 in an extracellular matrix-dependent, but MMP9-independent, manner. Furthermore, we observed that the NGAL-overexpressing cells tolerated increased iron levels in the culture environment, whereas the NGAL-underexpressing cells showed significant cell death after prolonged incubation in high-iron condition. Thus, overexpressing NGAL in colon carcinomas is an important regulatory molecule that integrates extracellular environment cues, iron metabolism, and intracellular small GTPase signaling in cancer migration and invasion. NGAL may therefore be a new target for therapeutic intervention in colorectal carcinoma.
AB - Expression of neutrophil gelatinase-associated lipocalin (NGAL)lipocalin2, a recently recognized iron regulatory protein that binds to matrix metalloproteinase-9 (MMP9), is increased in a spectrum of cancers, including those of the colorectum. Using colon carcinoma cell lines stably transfected with NGAL or antisense NGAL, we showed that NGAL overexpression altered subcellular localization of E-cadherin and catenins, decreased E-cadherin-mediated cellcell adhesion, enhanced cellmatrix attachment, and increased cell motility and in vitro invasion. Conversely, a decrease in NGAL enhanced more aggregated growth pattern and decreased in vitro invasion. We further showed that NGAL exerted these effects through the alteration of the subcellular localization of Rac1 in an extracellular matrix-dependent, but MMP9-independent, manner. Furthermore, we observed that the NGAL-overexpressing cells tolerated increased iron levels in the culture environment, whereas the NGAL-underexpressing cells showed significant cell death after prolonged incubation in high-iron condition. Thus, overexpressing NGAL in colon carcinomas is an important regulatory molecule that integrates extracellular environment cues, iron metabolism, and intracellular small GTPase signaling in cancer migration and invasion. NGAL may therefore be a new target for therapeutic intervention in colorectal carcinoma.
KW - Colon cancer
KW - E-cadherin
KW - Invasion
KW - MMP9
KW - NGAL
KW - Rac1
UR - http://www.scopus.com/inward/record.url?scp=65649126777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65649126777&partnerID=8YFLogxK
U2 - 10.1038/labinvest.2009.17
DO - 10.1038/labinvest.2009.17
M3 - Article
C2 - 19308044
AN - SCOPUS:65649126777
SN - 0023-6837
VL - 89
SP - 531
EP - 548
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 5
ER -